Natural killer cell receptor
Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay
15
Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells
7
Cocaine increases natural killer cell activity
5
Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
10
Contributions of natural killer cells to the immune response against Plasmodium
9
Natural Killer Cell Lymphoma in a Pediatric Patient With Inflammatory Bowel Disease
7
Structural basis for NKG2A/CD94 recognition of HLA-E.
28
Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome
9
Hofmeister, Valeska (2004): Expression und immunmodulatorische Funktion von HLA-G und seinen verkürzten Isoformen in Tumorzellinien. Dissertation, LMU München: Fakultät für Biologie
137
Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56dim natural killer cells
12
Transcriptional analysis of natural killer T cell development
334
Determination of natural killer cell function by flow cytometry.
6
Natural killer cells and natural killer T cells in Lyme arthritis
11
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
6
Role and Regulation of Myosin IIA in Natural Killer Cell Cytotoxicity
133
Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms
24
Soluble beta glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b opsonized target cells
13
Adult cancer related hemophagocytic lymphohistiocytosis – a challenging diagnosis: a case report
5
Regulation of immunity during visceral Leishmania infection
13
Immune cell therapy for hepatocellular carcinoma
11